4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

Background Recent advances have enabled noninvasive mapping of cardiac arrhythmias
with electrocardiographic imaging and noninvasive delivery of precise ablative radiation …

Background: Accurate and expedited identification of scar regions most prone to reentry is
needed to guide ventricular tachycardia (VT) ablation. We aimed to prospectively assess …

Background Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR)
provides tissue characterization of ventricular myocardium and scar that can be depicted as …

Abbreviations: 3D, three-dimensional; AF, atrial fibrillation; AP, accessory pathway; ARVC,
arrhythmogenic right ventricular cardiomyopathy; AT, atrial tachycardia; AVB, atrioventricular …

Objectives This study assessed the feasibility and potential benefit of performing ventricular
tachycardia (VT) substrate ablation procedures guided by cardiac magnetic resonance …

In the chronic stage of myocardial infarction, a significant number of patients develop life-
threatening ventricular tachycardias (VT) due to the arrhythmogenic nature of the remodeled …

Background: Several distinct risk factors for arrhythmia recurrence and mortality following
ventricular tachycardia (VT) ablation have been described. The effect of concurrent risk …